Search articles, podcasts and webinars on the MJA website.
Wiley Search is performed through the Wiley Online Library
Insight+ Search is performed through the insightplus.mja.com.au
3 Nov 2025
6 July 2026
3 August 2026
Rudi Louis Taylor-Bragge
Simon Rosenbaum, Grace McKeon, Gulsah Kurt, Oscar Lederman, Kemi Wright, Sabuj Kanti Mistry, Jackie E. Curtis, Philip B. Ward, Zachary Steel, Hamish Fibbins, Rachel Morell, Melissa C. Eaton, Andrew Watkins, Ben Harris-Roxas, Brendan Goodger, Eleanor Beck, Megan Teychenne, Joseph Firth, Davy Vancampfort, David Burns, Russell Roberts, Tristan Favaloro, Danielle Weber, Rosanna Barbero, Vasili Maroulis, Melissa Holmes, Stefan Mackenzie, Chiara Mastrogiovanni, Afsana Anwar, Uzma Choudhry, Catherine Sherrington, Jane Currie, Thomas Gadsden, Scott Teasdale
3 Nov 2025
6 July 2026
3 August 2026
Rudi Louis Taylor-Bragge
Simon Rosenbaum, Grace McKeon, Gulsah Kurt, Oscar Lederman, Kemi Wright, Sabuj Kanti Mistry, Jackie E. Curtis, Philip B. Ward, Zachary Steel, Hamish Fibbins, Rachel Morell, Melissa C. Eaton, Andrew Watkins, Ben Harris-Roxas, Brendan Goodger, Eleanor Beck, Megan Teychenne, Joseph Firth, Davy Vancampfort, David Burns, Russell Roberts, Tristan Favaloro, Danielle Weber, Rosanna Barbero, Vasili Maroulis, Melissa Holmes, Stefan Mackenzie, Chiara Mastrogiovanni, Afsana Anwar, Uzma Choudhry, Catherine Sherrington, Jane Currie, Thomas Gadsden, Scott Teasdale
View this article online at www.mja.com.au
Dr Greg Moore
Volume 205, Issue 7: 3 October, 2016. Dr Greg Moore is the head of Inflammatory Bowel Disease at Monash Health in Melbourne. In between endoscopies he talked with MJA news and online editor Cate Swannell about biosimilars and a possible safety concern with multi-switching. Available as a video here.
No spam, you can unsubscribe anytime you want.
By providing your information, you agree to our Terms of Use and our Privacy Policy.
Your email updates will use your name.
Thank you for subscribing to the MJA email alerts. Receive the latest content in your inbox.
